Enliven Therapeutics Director Sold Shares Worth Over $606K

Garland J. Scott, a Director at Enliven Therapeutics, reported the sale of 13,000 shares of Common Stock on October 1, 2026, at a weighted average price of $46.6707 per share, totaling $606,719. Following the transaction, the reporting person no longer directly owns Common Stock.